Polycythemia vera (NORD)

Polycythemia vera (NORD)

Heme & Onc

Heme & Onc

Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Hemophilia
Vitamin K deficiency
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Hemolytic-uremic syndrome
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Protein S deficiency
Antiphospholipid syndrome
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Blood histology
Erythropoietin
Iron deficiency anemia
Anemia of chronic disease
Sideroblastic anemia
Megaloblastic anemia
Aplastic anemia
Paroxysmal nocturnal hemoglobinuria
Autoimmune hemolytic anemia
Fanconi anemia
Hemolytic disease of the newborn
Hereditary spherocytosis
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate kinase deficiency
Sickle cell disease (NORD)
Beta-thalassemia
Alpha-thalassemia
Lead poisoning
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Diamond-Blackfan anemia
Acute intermittent porphyria
Porphyria cutanea tarda
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Langerhans cell histiocytosis
Mastocytosis (NORD)
Multiple myeloma
Monoclonal gammopathy of undetermined significance
Waldenstrom macroglobulinemia
Leukemoid reaction
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Ehrlichia and Anaplasma
Escherichia coli
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Plasmodium species (Malaria)
HIV (AIDS)
HIV and AIDS: Pathology review
Measles virus
Viral hepatitis: Pathology review
Viral hepatitis
Hepatitis C virus
Hepatitis medications
Dengue virus
Yellow fever virus
Cytomegalovirus
Epstein-Barr virus (Infectious mononucleosis)
Bleeding disorders: Clinical
Clostridium perfringens
Staphylococcus epidermidis
Staphylococcus aureus
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Strep)
Enterococcus
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Pseudomonas aeruginosa
Serratia marcescens
Nocardia
Klebsiella pneumoniae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Neisseria meningitidis
Brucella
Haemophilus influenzae
Mycobacterium avium complex (NORD)
Mycobacterium tuberculosis (Tuberculosis)
Mycoplasma pneumoniae
Borrelia species (Relapsing fever)
Borrelia burgdorferi (Lyme disease)
Varicella zoster virus
Human herpesvirus 8 (Kaposi sarcoma)
Herpes simplex virus
Adenovirus
Parvovirus B19
Human papillomavirus
JC virus (Progressive multifocal leukoencephalopathy)
Human T-lymphotropic virus
Candida
Pneumocystis jirovecii (Pneumocystis pneumonia)
Coccidioidomycosis and paracoccidioidomycosis
Histoplasmosis
Aspergillus fumigatus
Mucormycosis
Cryptococcus neoformans
Babesia
Cryptosporidium
Toxoplasma gondii (Toxoplasmosis)
Leishmania
Strongyloides stercoralis
Diphyllobothrium latum
Ancylostoma duodenale and Necator americanus

Transcript

Watch video only

In polycythemia vera, there are increased blood cell levels due to overproduction by the bone marrow, which is a soft tissue found within the bones.

Normally, about 45% of the total blood volume is made up of erythrocytes, or red blood cells, and their main function is to carry oxygen to tissues and bring carbon dioxide to the lungs so it can be expired. This value is called the hematocrit.

In polycythemia vera there’s an increase in red blood cell production.

It typically begins with a mutation in a single hematopoietic stem cell, which gives rise to red blood cells, white blood cells, and platelets.

In 90 percent of the affected individuals there is a mutation of the Janus Kinase 2 or JAK2 gene.

Normally, the kidneys produce erythropoietin which is a hormone that binds to receptors on the hematopoietic stem cells and activates JAK2 gene.

When that happens, it causes the cell to divide and thus produce more blood cells.

However, when there’s a mutation, it keeps JAK2 gene activated, and these cells are able to divide even in the absence of erythropoietin.

The mutated cells proliferate, and rapidly become the predominant hematopoietic cells in the bone marrow.

In time these cells start to die out and that’s when scar tissue forms.

At that point, the bone marrow can no longer produce blood cells, leading to anemia or low red blood cell levels, thrombocytopenia or low platelet levels, and leukopenia or low white blood cell levels. This is known as the spent phase.

And once the disease is in the spent phase, it’s really a different disease altogether - at that point it’s myelofibrosis.

The most common symptoms of polycythemia vera are fatigue, dizziness, increased sweating, redness in the face, blurred vision, and itchy skin especially after a hot shower.

Itchiness develops due to the increased number of basophils and mast cells which contain histamine that causes itching when released.

Splenomegaly or spleen enlargement is also common because the excess red blood cells buildup in the spleen, which usually helps with removing excess cells.

High turnover of red blood cells can cause build up of uric acid which leads to the inflammation of joints or gout and kidney stones.

Key Takeaways

Polycythemia vera is a bone marrow disorder in which there is an overproduction of blood cells, often caused by a JAK2 mutation within hematopoietic cells in the bone marrow. It can lead to elevated hemoglobin and hematocrit and predispose an individual to develop blood clots. Symptoms may include fatigue, weakness, headaches, dizziness, itching, and abdominal pain. Treatment may include medications to lower blood cell formation, and prevention of blood clots, phlebotomy, and radiation therapy.